All Glow Stack certificates

Glow Stack 70 mg Certificate of Analysis Batch APL-GLOW70-2607-02

Glow Stack 70 mg from batch APL-GLOW70-2607-02 was analysed on 19 July 2026 and measured 99.07% combined purity across GHK-Cu, TB-500 and BPC-157 by HPLC / Mass Spectrometry, passing all 5 release tests.

Combined purity
99.07%
Components
GHK-Cu, TB-500, BPC-157
Result
All 5 tests passed
Tested
19 July 2026
Method
HPLC / Mass Spectrometry
Net content
70.55 mg

Independent verification

Glow Stack 70 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.53% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-GLOW70-2608-01, net content 75.01 mg, verification code OZ-HPLCMS-TJ49.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 4

Certificate of Analysis Glow Stack 70 mg Batch APL-GLOW70-2607-02
Compound Mix
Glow Stack
Lot Number
APL-GLOW70-2607-02
Analysis Date
19 July 2026
Method
HPLC / Mass Spectrometry
Purity
99.07%
Net Content
70.55 mg
Glow Stack vial
Net Content
  • GHK-Cu50.36 mg
  • TB-50010.14 mg
  • BPC-15710.05 mg
Form
Lyophilised Powder
Manufactured
July 2026
Issued
20 July 2026
Document ID
APL-COA-GLOW70-2607-02
Verification Code
Batch traceable

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

mAUPDA 214 nm01883755637500123456 min 1.2741.454GHK-Cu1.7442.914TB-5003.204BPC-1573.6945.034

3 components resolved on a single gradient and assigned by retention time against individually run reference standards. Purity is reported as their combined peak area; the remaining 4 integrated peaks are unassigned process impurities. Component share of total peak area reflects UV response at 214 nm, not the mass ratio in the vial.

Peak List

#Time (min)Area% AreaAssignment
11.27421,4560.240—
21.4545,353,64859.884GHK-Cu
31.74427,7140.310—
42.9141,302,45614.569TB-500
53.2042,200,75424.617BPC-157
63.69422,3500.250—
75.03411,6220.130—

Analytical Results

TestSpecificationResultStatus
AppearanceBlue/Blue-Green Lyophilised PowderConformsPASS
Identity (MS)All components confirmedConfirmedPASS
Purity (HPLC)≥98.0% combined99.07%PASS
Total Peptide Content95–105%99.0%PASS
Endotoxins<0.5 EU/mg<0.30 EU/mgPASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 4

GHK-Cu

PubChem CID: 133697840 · CAS Number: 49557-75-7

Formula: C14H24CuN6O4 · MW: 403.92 g/mol · In this vial: 50.36 mg

SequenceGly-His-Lys

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Monitored (m/z)Detected (m/z)Relative Intensity
405404.91.61
427426.922.88

Detection assignment: GHK-Cu

Collected Mass Spectrum

Intensity ×107

01234100200300400500600700800 m/z 405427

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 3 of 4

TB-500

PubChem CID: 16132341 · CAS Number: 77591-33-4

Formula: C212H350N56O78S · MW: 4963.4 g/mol · In this vial: 10.14 mg

SequenceAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES (43 aa, N-terminally acetylated)

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Monitored (m/z)Detected (m/z)Relative Intensity
828828.270.6
994993.651.6
12421241.870.96

Detection assignment: TB-500

Collected Mass Spectrum

Intensity ×107

00.511.52500700900110013001500 m/z 8289941242

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 4 of 4

BPC-157

PubChem CID: 9941957 · CAS Number: 137525-51-0

Formula: C62H98N16O22 · MW: 1419.5 g/mol · In this vial: 10.05 mg

SequenceGEPPPGKPADDAGLV

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Monitored (m/z)Detected (m/z)Relative Intensity
474474.170.55
711710.741.16
14211420.490.42

Detection assignment: BPC-157

Collected Mass Spectrum

Intensity ×107

00.511.5020040060080010001200140016001800 m/z 4747111420

Verification Protocol

  • Identity confirmed separately for each component by mass spectrometry against its own expected ion channels.
  • Purity measured by HPLC as the combined area of every assigned component peak against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.